Added to YB: 2026-05-25
Pitch date: 2026-05-21
NRXS [neutral]
NeurAxis, Inc.
Author Info
Microcap Opportunities is a community dedicated to finding the best opportunities in the MicroCap space for US and Canadian listings primarily. Sign up for the newsletter.
Company Info
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
Market Cap
$95.1M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-13.66
P/E
-10.13
EV/Sales
20.65
Sector
Health Care Equipment and Supplies
Category
growth
NeurAxis VA Ramp
NRXS (update): VA contract (Dec 2025) adoption ahead of expectations, yet zero analyst models include VA rev. 210K addressable VA patients x $4K/treatment = $840M TAM. electroCore comp hit $1M/qtr after 4 qtrs; NRXS 8x higher ASP + no competition should drive faster ramp. 0.25% penetration = $2M+ 2026; 1-2% by 2028 = $8-17M annual VA rev. Q2 call Aug catalyst for re-rating.
Read full article (3 min)